Glenmark Pharmaceuticals Inc., USA is recalling 5,136 tubes of Mometasone Furoate Cream, USP, 0.1% (45 g). This prescription topical medication is being recalled because of quality deviations that resulted in consumer complaints about a "gritty texture" in the cream. While this is a voluntary recall initiated by the firm, using a product with an improper texture may affect how the medication is absorbed or cause localized irritation.
The gritty texture indicates a deviation from standard manufacturing practices, which can compromise the consistency and performance of the medication on the skin. No specific injuries have been reported, but the defect may lead to skin irritation or reduced effectiveness of the treatment.
Return for refund and medical consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.